Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cytomegalovirus: pathogen, paradigm, and puzzle
Michael Boeckh, Adam P. Geballe
Michael Boeckh, Adam P. Geballe
View: Text | PDF
Science in Medicine

Cytomegalovirus: pathogen, paradigm, and puzzle

  • Text
  • PDF
Abstract

Human cytomegalovirus (CMV), one of the eight herpesviruses that commonly infect humans, is best known for its propensity to cause disease in immunocompromised patients, especially transplant recipients, patients with advanced AIDS, and congenitally infected newborns. Advances in molecular virology coupled with improvements in diagnostic methods and treatment options have vastly improved our understanding of and ability to manage CMV, but many uncertainties remain, including the mechanisms of persistence and pathogenesis and its hypothesized roles in a variety of human illnesses. Here we review recent advances that are reshaping our view and approach to this fascinating virus.

Authors

Michael Boeckh, Adam P. Geballe

×

Figure 1

CMV genome.

Options: View larger image (or click on image) Download as PowerPoint
CMV genome.
The genome of CMV clinical isolates, such as the Merlin stra...
The genome of CMV clinical isolates, such as the Merlin strain depicted here (GenBank accession no. NC_006273; ref. 118), consists of long (brown) and short (orange) DNA segments, each of which has unique regions (UL and US) flanked by inverted repeats (TRL/IRL and IRS/TRS). These repeats contain segment-specific sequences (b, b′, c, and c′) as well as a variable number of shared a sequence repeats in direct orientation at the genomic ends and in an inverted orientation at the junction of the two segments. Laboratory-adapted strains often have deletions of multiple genes at the right end of the UL segment and their replacement with genes duplicated from the left end, resulting in longer TRL and IRL regions (dashed boxes) compared with clinical strains (21, 118). The gene names in this region are not always sequential because of historical precedence in nomenclature assignments and because of rearrangements among strains. The relative position and orientation of transcripts corresponding to several genes are shown, along with grouping by their putative functional classifications (24, 31, 43–45, 47). This diagram is a simplification, since some and possibly many of the genes shown here have more than one function and other genes that are not shown likely contribute to the indicated processes.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts